Inhaled drug developer Avalyn files for U.S. IPO
Source: SeekingAlpha
2026-04-10 12:23:06 ET
More on Avalyn Pharma Inc.
- Avalyn Pharma Begins IPO Process For Pulmonary Fibrosis Pipeline
- Financial information for Avalyn Pharma Inc.
Read the full article on Seeking Alpha
For further details see:
Inhaled drug developer Avalyn files for U.S. IPO
Novo Nordisk A/S
NASDAQ: NVO
NVO Trading
0.36% G/L:
$37.54 Last:
5,872,074 Volume:
$38.30 Open:
NVO Latest News
April 08, 2026 02:35:00 pm
Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker?
April 08, 2026 12:33:51 pm
Anthropic Inks US$400 Million Deal for AI Biotech Startup Coefficient Bio
NVO Stock Data
$220,548,675,000
4,194,421,000
N/A
749
N/A
Biotechnology & Life Sciences
Healthcare
DK
Bagsvaerd
